Page last updated: 2024-08-17

isatin and Triple Negative Breast Neoplasms

isatin has been researched along with Triple Negative Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Aziz, HA; Almahli, H; El-Naggar, M; Elaasser, MM; Eldehna, WM; Elgez, A; Fares, M1
Abdel-Aziz, HA; Al-Ansary, GH; Al-Dhfyan, A; Almahli, H; Aly, MH; Eldehna, WM; Ghabbour, HA; Ismael, OE1

Other Studies

2 other study(ies) available for isatin and Triple Negative Breast Neoplasms

ArticleYear
Novel Thiazolidinone/Thiazolo[3,2-
    Molecules (Basel, Switzerland), 2018, 06-12, Volume: 23, Issue:6

    Topics: Antineoplastic Agents; bcl-2-Associated X Protein; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 2-Ring; Humans; In Vitro Techniques; Isatin; MCF-7 Cells; Molecular Structure; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship; Triple Negative Breast Neoplasms

2018
Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents.
    Journal of enzyme inhibition and medicinal chemistry, 2017, Volume: 32, Issue:1

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Humans; Hydrazines; In Vitro Techniques; Isatin; Phthalazines; Triple Negative Breast Neoplasms

2017